Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Shares withheld for taxes SVP & General Counsel gave up 26,941 shares (to pay taxes)
  2. 4 Open-market buy President and CEO bought 10,000 shares at $4.76 ($47,600)
  3. 4 Open-market buy President and CEO bought 10,000 shares at $4.76 ($47,600)
  4. 4 Open-market buy President and CEO bought 10,000 shares at an average $4.77 ($47,650)
  5. 4 Open-market buy President and CEO bought 10,000 shares at $4.46 ($44,640)
  6. 4 Open-market buy SVP, CFO & Treasurer bought 2,000 shares at $4.39 ($8,779)
  7. 4 Grant or award SVP, Chief Marketing Officer acquired 125,000 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 450,000 shares (grant or award)
  9. 4 Grant or award SVP, CFO & Treasurer acquired 125,000 shares (grant or award)
  10. 4 Grant or award SVP, Business Development acquired 125,000 shares (grant or award)
  11. 4 Grant or award SVP & General Counsel acquired 125,000 shares (grant or award)
  12. 4 Open-market sale Director sold 5,000 shares at $5.17 ($25,863)
  13. 4 Open-market sale SVP, CFO & Treasurer sold 2,251 shares at $5.92 ($13,327)
  14. 4 Grant or award Director acquired 21,887 shares (grant or award)
  15. 4 Grant or award Director acquired 20,529 shares (grant or award)
  16. 4 Grant or award Director acquired 20,529 shares (grant or award)
  17. 4 Grant or award Director acquired 20,529 shares (grant or award)
  18. 4 Grant or award Director acquired 20,529 shares (grant or award)
  19. 4 Open-market sale SVP & General Counsel sold 17,088 shares at an average $4.29 ($73,313)
  20. 4 Open-market sale SVP, Chief Marketing Officer sold 16,727 shares at an average $4.30 ($71,921)

Page 3 of 29 · 579 filings